{
  "id": "clinical#screening_cues_b1b1ee92",
  "content": "morbid hallucinogen-induced psychotic disorder and hallucinogen\nuse disorder, only the hallucinogen-induced psychotic disorder code\nis given, with the 4th character indicating whether the comorbid hal-\nlucinogen use disorder is mild, moderate, or severe: F16.159 for mild\nhallucinogen use disorder with hallucinogen-induced psychotic disor-\nder or F16.259 for a moderate or severe hallucinogen use disorder\nwith hallucinogen-induced psychotic disorder.\nSpecify current severity:\n305.30 (F16.10) Mild: Presence of 2–3 symptoms\n304.50 (F16.20) Moderate: Presence of 4–5 symptoms\n304.50 (F16.20) Severe: Presence of 6 or more symptoms\nPhencyclidine Intoxication\nA. Recent use of phencyclidine (or a pharmacologically similar sub-\nstance).\nB. Clinically significant problematic behavioral changes (e.g., bellig-\nerence, assaultiveness, impulsiveness, unpredictability, psycho-\nmotor agitation, impaired judgment) that developed during, or\nshortly after, phencyclidine use.\nC. Within 1 hour, two (or more) of the following signs or symptoms:\nOther Hallucinogen Intoxication 249\nNote: When the drug is smoked, “snorted,” or used intravenously,\nthe onset may be particularly rapid.\n1. Vertical or horizontal nystagmus.\n2. Hypertension or tachycardia.\n3. Numbness or diminished responsiveness to pain.\n4. Ataxia.\n5. Dysarthria.\n6. Muscle rigidity.\n7. Seizures or coma.\n8. Hyperacusis.\nD. The signs or symptoms are not attributable to another medical",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "screening_cues"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues morbid hallucinogen-induced psychotic disorder and hallucinogen\nuse disorder, only the hallucinogen-induced psychotic disorder code\nis given, with the 4th character indicating whether the comorbid hal-\nlucinogen use disorder is mild, moderate, or severe: F16.159 for mild\nhallucinogen use disorder with hallucinogen-induced psychotic disor-\nder or F16.259 for a moderate or severe hallucinogen use disorder\nwith hallucinogen-induced psychotic disorder.\nSpecify current severity:\n305.30 (F16.10) Mild: Presence of 2–3 symptoms\n304.50 (F16.20) Moderate: Presence of 4–5 symptoms\n304.50 (F16.20) Severe: Presence of 6 or more symptoms\nPhencyclidine Intoxication\nA. Recent use of phencyclidine (or a pharmacologically similar sub-\nstance).\nB. Clinically significant problematic behavioral changes (e.g., bellig-\nerence, assaultiveness, impulsiveness, unpredictability, psycho-\nmotor agitation, impaired judgment) that developed during, or\nshortly after, phencyclidine use.\nC. Within 1 hour, two (or more) of the following signs or symptoms:\nOther Hallucinogen Intoxication 249\nNote: When the drug is smoked, “snorted,” or used intravenously,\nthe onset may be particularly rapid.\n1. Vertical or horizontal nystagmus.\n2. Hypertension or tachycardia.\n3. Numbness or diminished responsiveness to pain.\n4. Ataxia.\n5. Dysarthria.\n6. Muscle rigidity.\n7. Seizures or coma.\n8. Hyperacusis.\nD. The signs or symptoms are not attributable to another medical Morbid hallucinogen-induced psychotic disorder and hallucinogen\nuse disorder, only the hallucinogen-induced psychotic disorder code\nis given, with the 4th character indicating whether the comorbid hal-\nlucinogen use diso..."
}